A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study

A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study

ABSTRACTObjectives: To describe the incorporation of monoclonal antibodies (mAb) in real-world (RW) practice for the treatment of patients with relapsed refractory multiple myeloma (RRMM) in a setting with other treatment alternatives.Methods: This was an observational, multicenter, ambispective stu...

Full description

Bibliographic Details
Main Authors: Rafael Ríos-Tamayo, Juan Alfons Soler, Ricarda García-Sánchez, Ernesto Pérez Persona, Mario Arnao, Antoni García-Guiñón, Abel Domingo, Miriam González-Pardo, Javier de la Rubia, María Victoria Mateos
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Hematology
Subjects:
Relapsed-refractory multiple myeloma
real-world
monoclonal antibodies
daratumumab
standard of care
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2023.2178997

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2023.2178997

Similar Items